Satellite Banner
Technology Networks Header
Tuesday, September 16, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
QIAGEN Launch of 14 New Cancer Gene Panels
Wednesday, July 16, 2014
QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes.

Bioo Scientific Launches NEXTflex Cell Free DNA-Seq Kit
Friday, July 04, 2014
Optimized for ctDNA and cfDNA library preparation.

Consistent & Efficient Purification of NGS Library Reactions
Tuesday, June 24, 2014
MagSi-NGSPREP offers an efficient solution for DNA clean-up and size selection.

Bioo Scientific Releases Sciclone and Biomek Protocols
Saturday, June 21, 2014
Protocols designed to eliminate NGS library prep bottlenecks.

DNASTAR Releases Lasergene 12 Software
Thursday, June 19, 2014
Lasergene 12 improves sequence alignments and NGS accuracy.

New Molecular Biology Tools Drive Efficiency across a Range of Applications
Wednesday, June 11, 2014
New convenience features and rapid protocols leave more time for analysis and discovery.

Agilent Introduces SureSelectQXT Target Enrichment Kits
Wednesday, June 04, 2014
Solution empowers clinical research sequencing with quick workflow, minimal sample input.

OGT to Sell Cytocell Products Direct in North America
Monday, June 02, 2014
The acquisition brings immediate customer benefits.

Contract Research Organizations Adopt Ion Torrent Next-Generation Sequencing Platform
Monday, June 02, 2014
MolecularMD and Selah Genomics to Use Oncomine Cancer Research Panel for Clinical Trial Design.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 205
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv